Kanto Tatsuya

カントウタツヤ | Kanto Tatsuya

Affiliation and department：
Job title：研究センター長

Research field (1)： Gastroenterology

Research theme for competitive and other funds (11)：

2017 - 2020 Establishment of strategy for the prevention of HBV carriers by HB vaccination - epidemiologic and immunogenomics approach
2014 - 2017 Investigation of anti-angiogenesis therapy against hepatocellular carcinoma targeting liver-infiltrating myeloid cells.
2010 - 2012 Investigation for the mechanisms of immune tolerance against HCV mediated by tryptophan-catalyzing enzyme, IDO
2010 - 2012 Development of novel therapy for hepatocellular carcinoma targeting of bone marrow-derived angiogenesis precursor
2008 - 2010 Immunological analysis and new immunotherapy of chronic hepatitis C

Show all

Papers (353)：

Kazuya Okushin, Tatsuya Kanto, Masaaki Korenaga, Kazuhiko Ikeuchi, Toshiyuki Kishida, Akira Kado, Mitsuhiro Fujishiro, Takeya Tsutsumi, Tomoyuki Takura, Hiroshi Yotsuyanagi. Real-world trends in acute viral hepatitis in Japan: A nationwide questionnaire-based survey. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Masaaki Mino, Akitoshi Sano, Eiji Kakazu, Hiroko Matsubara, Keisuke Kakisaka, Takayuki Kogure, Katsunori Sekine, Yoshihiko Aoki, Masatoshi Imamura, Michitaka Matsuda, et al. Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults. Journal of gastroenterology. 2024
Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, Hisateru Tachimori, Koji Uchino, Ryo Nakagomi, Tomoharu Yamada, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, et al. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL). Scientific reports. 2024. 14. 1. 2826-2826
Taizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto. Active role of the immune system in metabolic dysfunction-associated steatotic liver disease. Gastroenterology report. 2024. 12. goae089
Yosuke Osawa, Hironari Kawai, Keigo Nakashima, Yuichi Nakaseko, Daisuke Suto, Keisuke Yanagida, Tomomi Hashidate-Yoshida, Taizo Mori, Sachiyo Yoshio, Takaaki Ohtake, et al. Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis. PloS one. 2024. 19. 5. e0303296

ｍore...

MISC (277)：

Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, Koji Uchino, Ryo Nakagomi, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, et al. TRANSITION OF TREATMENT SELECTION FOR PRIMARY LIVER CANCER AND DECOMPENSATED CIRRHOSIS IN MULTIPLE ADMISSIONS: ANALYSIS OF A NATIONWIDE REGISTRY FOR ADVANCED LIVER DISEASES (REAL). HEPATOLOGY. 2022. 76. S1340-S1341
Kazuya Okushin, Ryosuke Tateishi, Arata Takahashi, Koji Uchino, Ryo Nakagomi, Yuki Matsushita, Makoto Moriyama, Shigeyuki Kurosaki, Tsuyoshi Fukumoto, Satoshi Kawamura, et al. CURRENT STATUS OF PRIMARY LIVER CANCER AND DECOMPENSATED CIRRHOSIS IN JAPAN: LAUNCH OF A NATIONWIDE REGISTRY. HEPATOLOGY. 2021. 74. 629A-630A
Yuzuru Sakamoto, Sachiyo Yoshio, Akihisa Nagatsu, Yoh Asahi, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Toshiya Kamiyama, Tatsuya Kanto, Akinobu Taketomi. Increased frequency of PD-1+CD57+Siglec-7-dysfunctional NK cells in patients with nonalcoholic fatty liver disease. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
由雄祥代, 島垣智成, 吉田祐一, 筒井由梨子, 河合裕成, 吉川詩織, 山添太士, 森泰三, 大澤陽介, 橋田竜騎, et al. NAFLD由来肝がん患者における血清ミオスタチンおよび筋肉脂肪化と術後予後との関連-運動療法によるミオスタチン制御の可能性. 肝臓. 2020. 61. Supplement 1
島垣智成, 島垣智成, 由雄祥代, 玉城信治, 筒井由梨子, 吉田祐一, 河合裕成, 山添太士, 森泰三, 大澤陽介, et al. 肝細胞癌ラジオ波焼灼療法施行症例における新規血清肝癌診断バイオマーカーMFG-E8の有効性の検討. 肝臓. 2020. 61. Supplement 1

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page